InvestorsHub Logo
Followers 13
Posts 1020
Boards Moderated 0
Alias Born 07/19/2013

Re: None

Thursday, 03/22/2018 12:28:53 PM

Thursday, March 22, 2018 12:28:53 PM

Post# of 182912
Microcap Mymetics Corp. (OTCQB:MYMX ) .02 on watch!
Partnerships:

Sanofi Pasteur (vaccine unit of Sanofi : NYSE: SNY) --- Oct.2016 - present
Astellas Pharma (2nd Largest Japanese Pharma Co.)-- Jan.2014 - July 2016
Catalent (NYSE:CTLT) ---April 2015 - Present
Bachem (SIX:BANB) ------April 2015 - Present
Upperton, UK -------------- April 2015 - Present
Chimera Biotec, Germany-April 2015 - Present
Texas Biomedical Research Institute - Sept.2014 - Present

Funding Organizations:
Bill & Melinda Gates Foundation - HIV-1 vaccine
PATH MVI ------------------------------ Malaria Transmission Blocking Vaccine
Swiss Tropical & Public Health Institute --- Malaria Vaccine
European Union Horizon 2020---------------MACIVIVA (Manufacturing Process For Cold-Chain Independent Virosome based Vaccines)--Mymetics is leading a consortium of 4 other companies.

"click" on Company Overview: https://www.mymetics.com/about/

Would have been better in the hands of the Americans pps wise since 2012?
Dr. Christopher Henney, currently Cascadian Therapeutics(CSCA)formerly Oncothyreon & Anthera Pharmaceuticals(ANTH) Chairman of the Board; Director at Cyclacel Pharmaceuticals and former Dendreon co-founder & CEO was once on board with this unknown microcap as Chairman of BOD but seems like had a disagreement with the largest shareholder that led him and his Dendreon protege to leave in less than a year.
https://www.xconomy.com/san-francisco/2012/04/11/mymetics-ropes-in-dendreon-kpcb-vets-to-restart-vaccine-developer/

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.